Carrier-Free Silibinin/Sorafenib Microparticles Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Fatty Acid Metabolism

Han F, Wang H, Wang L, Fan L, Peng S, Hou X, Shu X, Sun B, Liu Y

International Journal of Nanomedicine 2025, 20:6949-6962

Published Date: 30 May 2025